SA Pharmaceutical Journal - Volume 79, Issue 3, 2012
Volume 79, Issue 3, 2012
Author Sybil SeokaSource: SA Pharmaceutical Journal 79, pp 6 –7 (2012)More Less
This address was given at the South African Association of Pharmacists in Industry Regulatory (SAAPI) Update Conference 2012. As pharmacists, we all need to be aware of matters that affect sectors other than the one in which we work, particularly when they impact on the safety, efficacy, and quality of medicines.
Author Natalie SchellackSource: SA Pharmaceutical Journal 79, pp 10 –13 (2012)More Less
Febrile seizures may be the most common seizure disorder affecting children between the ages of six and 60 months. Febrile seizures may be classified as simple, complex and symptomatic. Simple febrile seizures may last for less than 15 minutes. Possible causes of febrile seizures may include a genetic predisposition, infection and certain vaccines. The management of febrile seizures includes the use of antipyretics, and depending on the duration of the seizure, the use of anticonvulsants. This article deals with the management of febrile seizures in paediatrics. Incorporating the pharmacist as part of the clinical team, and using appropriate educational tools, may assist febrile seizure prognosis.
Author James KerSource: SA Pharmaceutical Journal 79, pp 14 –16 (2012)More Less
It is estimated that at the age of 40 years, the lifetime risk to develop coronary artery disease is one in two for men, and one in three for women. Atherosclerotic coronary artery disease begins in childhood, and risk factors influence the development of atherosclerosis throughout one's lifetime.
Author Karen Van RensburgSource: SA Pharmaceutical Journal 79, pp 18 –21 (2012)More Less
Gout, a condition caused by increased levels of serum uric acid, is an extremely painful condition and often only treated when an acute attack is experienced. The factors contributing to raised serum uric acid levels, for example lifestyle choices and the use of various medications, will be evaluated in this article, as well as the role of medicines used in the prevention and management of gout.
Author Sumari DavisSource: SA Pharmaceutical Journal 79, pp 22 –26 (2012)More Less
The failure of diet and exercise to manage type 2 diabetes mellitus usually requires the introduction of an oral hypoglycaemic drug. Currently, metformin remains the first-line agent, particularly in overweight patients. Shorter-acting sulphonylureas, such as glipizide, may be considered in normal or underweight patients, and in those who cannot use or tolerate metformin. Alpha-glucosidase inhibitors (acarbose) may reduce cardiovascular risk, while thiazolidinediones (glitazones) have been associated with higher cardiovascular risk. Bile-acid sequestrants and bromocriptine mesylate may be contemplated as adjunct treatment in type 2 diabetes mellitus. Dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose transporter-2 (SGTL-2) inhibitors are promising new therapeutic classes for the treatment of type 2 diabetes mellitus.
Source: SA Pharmaceutical Journal 79, pp 28 –30 (2012)More Less
Osmotic controlled-release oral delivery system (OROS®) hydromorphone extended-release (Jurnista®) is a once-daily formulation of the opioid agonist hydromorphone that uses OROS® technology to deliver the analgesic at a near-constant rate over the 24-hour dosing interval. OROS® technology is used in a number of commercially available medicines, and OROS® hydromorphone was developed to provide 24-hour analgesia for severe pain, and as a result, lessen the need for breakthrough pain medication.
Source: SA Pharmaceutical Journal 79 (2012)More Less
The Academy of Pharmaceutical Sciences, together with the organising committee of the Discipline of Pharmaceutical Sciences at the University of KwaZulu-Natal (UKZN) for the International Conference on Pharmacy and Pharmaceutical Sciences (ICPPS 2011), put smiles on the faces of intellectually impaired learners between the age of six and 23 years at Sunfield Home School, when they received numerous books and a bookshelf donated by conference delegates and the Academy.
Source: SA Pharmaceutical Journal 79, pp 32 –35 (2012)More Less
The aim of infection control is to utilise available resources in a manner that ensures a safe environment, and provides a maximum level of protection for patients and staff. The five fundamental infection-control measures are surveillance, isolation, hand washing, disinfection, and sterilisation.
The aim of this study was to investigate the status and awareness of infection control policies and procedures among doctors and nurses in three public hospitals in the greater Durban area at district, regional, and tertiary, levels of healthcare.
Author Wim GrobbelaarSource: SA Pharmaceutical Journal 79 (2012)More Less
Community pharmacies have always been connected to medicines, and to providing healthcare services to society.
The role of the pharmacist has evolved over the past three decades, and in many settings, the pharmacist's role has shifted from a primary focus on medication dispensing, to one of providing patient care. Traditionally, the practice of a pharmacist has been that of interpreting, evaluating, and implementing medical orders and dispensing medications. However, the practice of pharmacy has expanded to include determining optimal, evidence-based medication management, monitoring adverse drug events, educating patients on medication use, and collaborating with other health professionals in the management of acute and chronic diseases.
Source: SA Pharmaceutical Journal 79, pp 37 –39 (2012)More Less
Source: SA Pharmaceutical Journal 79, pp 40 –41 (2012)More Less
On 2 March 2012, the South African Pharmacy Council published three board notices in the Government Gazette?. They are effective immediately.
Two of the three notices contain minimum standards that form part of the Good Pharmacy Practice rules. Draft copies were published for comment in 2011.
Author Cedric PrattSource: SA Pharmaceutical Journal 79 (2012)More Less